Abstract
A recurring point mutation in MYOD1 is found in 10% of embryonal rhabdomyosarcomas (ERMS).
©2014 American Association for Cancer Research.
MeSH terms
-
Cell Differentiation
-
Humans
-
MAP Kinase Signaling System
-
MyoD Protein / genetics*
-
Phosphatidylinositol 3-Kinases / metabolism*
-
Point Mutation
-
Prognosis
-
Rhabdomyosarcoma, Embryonal / genetics*
-
Rhabdomyosarcoma, Embryonal / pathology
Substances
-
MyoD Protein
-
MyoD1 myogenic differentiation protein
-
Phosphatidylinositol 3-Kinases